Cite Filings / TCRT / 0000921895-25-001912

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Alaunos Therapeutics, Inc. Filed 2025-07-01 Acc 0000921895-25-001912

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-10-30 SCHEDULE 13D Beneficial Ownership Report
2025-07-02 8-K Delisting notice · Executive or director change
2025-07-01 SCHEDULE 13D Beneficial Ownership Report
2025-06-26 4 Director acquired 20,804 shares (grant or award)
2025-06-26 8-K Material agreement · Regulation FD disclosure
2025-06-26 8-K Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
2025-05-14 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…